Eye drops or eyedrops are liquid drops applied directly to the surface of the eye usually in small amounts such as a single drop or a few drops.
The global Ophthalmic Eye Dropper market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Ophthalmic Eye Dropper Industry Forecast” looks at past sales and reviews total world Ophthalmic Eye Dropper sales in 2023, providing a comprehensive analysis by region and market sector of projected Ophthalmic Eye Dropper sales for 2024 through 2030. With Ophthalmic Eye Dropper sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ophthalmic Eye Dropper industry.
This Insight Report provides a comprehensive analysis of the global Ophthalmic Eye Dropper landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ophthalmic Eye Dropper portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ophthalmic Eye Dropper market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ophthalmic Eye Dropper and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ophthalmic Eye Dropper.
United States market for Ophthalmic Eye Dropper is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Ophthalmic Eye Dropper is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Ophthalmic Eye Dropper is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Ophthalmic Eye Dropper players cover AbbVie Inc., Alcon, Pfizer, Bausch & Lomb Incorporated and Novartis AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmic Eye Dropper market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Prescription Drugs
OTC Drugs
Segmentation by application
Dry Eye
Glaucoma
Allergies
Conjunctivitis
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AbbVie Inc.
Alcon
Pfizer
Bausch & Lomb Incorporated
Novartis AG
Sun Pharmaceutical
Sandoz
AptarGroup, Inc.
Daewoo Pharm
Optaderm Pharma
Silgan Dispensing Systems
Key Questions Addressed in this Report
What is the 10-year outlook for the global Ophthalmic Eye Dropper market?
What factors are driving Ophthalmic Eye Dropper market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ophthalmic Eye Dropper market opportunities vary by end market size?
How does Ophthalmic Eye Dropper break out type, application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ophthalmic Eye Dropper Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Ophthalmic Eye Dropper by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Ophthalmic Eye Dropper by Country/Region, 2019, 2023 & 2030
2.2 Ophthalmic Eye Dropper Segment by Type
2.2.1 Prescription Drugs
2.2.2 OTC Drugs
2.3 Ophthalmic Eye Dropper Sales by Type
2.3.1 Global Ophthalmic Eye Dropper Sales Market Share by Type (2019-2024)
2.3.2 Global Ophthalmic Eye Dropper Revenue and Market Share by Type (2019-2024)
2.3.3 Global Ophthalmic Eye Dropper Sale Price by Type (2019-2024)
2.4 Ophthalmic Eye Dropper Segment by Application
2.4.1 Dry Eye
2.4.2 Glaucoma
2.4.3 Allergies
2.4.4 Conjunctivitis
2.4.5 Others
2.5 Ophthalmic Eye Dropper Sales by Application
2.5.1 Global Ophthalmic Eye Dropper Sale Market Share by Application (2019-2024)
2.5.2 Global Ophthalmic Eye Dropper Revenue and Market Share by Application (2019-2024)
2.5.3 Global Ophthalmic Eye Dropper Sale Price by Application (2019-2024)
3 Global Ophthalmic Eye Dropper by Company
3.1 Global Ophthalmic Eye Dropper Breakdown Data by Company
3.1.1 Global Ophthalmic Eye Dropper Annual Sales by Company (2019-2024)
3.1.2 Global Ophthalmic Eye Dropper Sales Market Share by Company (2019-2024)
3.2 Global Ophthalmic Eye Dropper Annual Revenue by Company (2019-2024)
3.2.1 Global Ophthalmic Eye Dropper Revenue by Company (2019-2024)
3.2.2 Global Ophthalmic Eye Dropper Revenue Market Share by Company (2019-2024)
3.3 Global Ophthalmic Eye Dropper Sale Price by Company
3.4 Key Manufacturers Ophthalmic Eye Dropper Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ophthalmic Eye Dropper Product Location Distribution
3.4.2 Players Ophthalmic Eye Dropper Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Ophthalmic Eye Dropper by Geographic Region
4.1 World Historic Ophthalmic Eye Dropper Market Size by Geographic Region (2019-2024)
4.1.1 Global Ophthalmic Eye Dropper Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Ophthalmic Eye Dropper Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Ophthalmic Eye Dropper Market Size by Country/Region (2019-2024)
4.2.1 Global Ophthalmic Eye Dropper Annual Sales by Country/Region (2019-2024)
4.2.2 Global Ophthalmic Eye Dropper Annual Revenue by Country/Region (2019-2024)
4.3 Americas Ophthalmic Eye Dropper Sales Growth
4.4 APAC Ophthalmic Eye Dropper Sales Growth
4.5 Europe Ophthalmic Eye Dropper Sales Growth
4.6 Middle East & Africa Ophthalmic Eye Dropper Sales Growth
5 Americas
5.1 Americas Ophthalmic Eye Dropper Sales by Country
5.1.1 Americas Ophthalmic Eye Dropper Sales by Country (2019-2024)
5.1.2 Americas Ophthalmic Eye Dropper Revenue by Country (2019-2024)
5.2 Americas Ophthalmic Eye Dropper Sales by Type
5.3 Americas Ophthalmic Eye Dropper Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ophthalmic Eye Dropper Sales by Region
6.1.1 APAC Ophthalmic Eye Dropper Sales by Region (2019-2024)
6.1.2 APAC Ophthalmic Eye Dropper Revenue by Region (2019-2024)
6.2 APAC Ophthalmic Eye Dropper Sales by Type
6.3 APAC Ophthalmic Eye Dropper Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Ophthalmic Eye Dropper by Country
7.1.1 Europe Ophthalmic Eye Dropper Sales by Country (2019-2024)
7.1.2 Europe Ophthalmic Eye Dropper Revenue by Country (2019-2024)
7.2 Europe Ophthalmic Eye Dropper Sales by Type
7.3 Europe Ophthalmic Eye Dropper Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ophthalmic Eye Dropper by Country
8.1.1 Middle East & Africa Ophthalmic Eye Dropper Sales by Country (2019-2024)
8.1.2 Middle East & Africa Ophthalmic Eye Dropper Revenue by Country (2019-2024)
8.2 Middle East & Africa Ophthalmic Eye Dropper Sales by Type
8.3 Middle East & Africa Ophthalmic Eye Dropper Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ophthalmic Eye Dropper
10.3 Manufacturing Process Analysis of Ophthalmic Eye Dropper
10.4 Industry Chain Structure of Ophthalmic Eye Dropper
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ophthalmic Eye Dropper Distributors
11.3 Ophthalmic Eye Dropper Customer
12 World Forecast Review for Ophthalmic Eye Dropper by Geographic Region
12.1 Global Ophthalmic Eye Dropper Market Size Forecast by Region
12.1.1 Global Ophthalmic Eye Dropper Forecast by Region (2025-2030)
12.1.2 Global Ophthalmic Eye Dropper Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ophthalmic Eye Dropper Forecast by Type
12.7 Global Ophthalmic Eye Dropper Forecast by Application
13 Key Players Analysis
13.1 AbbVie Inc.
13.1.1 AbbVie Inc. Company Information
13.1.2 AbbVie Inc. Ophthalmic Eye Dropper Product Portfolios and Specifications
13.1.3 AbbVie Inc. Ophthalmic Eye Dropper Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 AbbVie Inc. Main Business Overview
13.1.5 AbbVie Inc. Latest Developments
13.2 Alcon
13.2.1 Alcon Company Information
13.2.2 Alcon Ophthalmic Eye Dropper Product Portfolios and Specifications
13.2.3 Alcon Ophthalmic Eye Dropper Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Alcon Main Business Overview
13.2.5 Alcon Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Ophthalmic Eye Dropper Product Portfolios and Specifications
13.3.3 Pfizer Ophthalmic Eye Dropper Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Bausch & Lomb Incorporated
13.4.1 Bausch & Lomb Incorporated Company Information
13.4.2 Bausch & Lomb Incorporated Ophthalmic Eye Dropper Product Portfolios and Specifications
13.4.3 Bausch & Lomb Incorporated Ophthalmic Eye Dropper Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Bausch & Lomb Incorporated Main Business Overview
13.4.5 Bausch & Lomb Incorporated Latest Developments
13.5 Novartis AG
13.5.1 Novartis AG Company Information
13.5.2 Novartis AG Ophthalmic Eye Dropper Product Portfolios and Specifications
13.5.3 Novartis AG Ophthalmic Eye Dropper Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Novartis AG Main Business Overview
13.5.5 Novartis AG Latest Developments
13.6 Sun Pharmaceutical
13.6.1 Sun Pharmaceutical Company Information
13.6.2 Sun Pharmaceutical Ophthalmic Eye Dropper Product Portfolios and Specifications
13.6.3 Sun Pharmaceutical Ophthalmic Eye Dropper Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Sun Pharmaceutical Main Business Overview
13.6.5 Sun Pharmaceutical Latest Developments
13.7 Sandoz
13.7.1 Sandoz Company Information
13.7.2 Sandoz Ophthalmic Eye Dropper Product Portfolios and Specifications
13.7.3 Sandoz Ophthalmic Eye Dropper Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Sandoz Main Business Overview
13.7.5 Sandoz Latest Developments
13.8 AptarGroup, Inc.
13.8.1 AptarGroup, Inc. Company Information
13.8.2 AptarGroup, Inc. Ophthalmic Eye Dropper Product Portfolios and Specifications
13.8.3 AptarGroup, Inc. Ophthalmic Eye Dropper Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 AptarGroup, Inc. Main Business Overview
13.8.5 AptarGroup, Inc. Latest Developments
13.9 Daewoo Pharm
13.9.1 Daewoo Pharm Company Information
13.9.2 Daewoo Pharm Ophthalmic Eye Dropper Product Portfolios and Specifications
13.9.3 Daewoo Pharm Ophthalmic Eye Dropper Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Daewoo Pharm Main Business Overview
13.9.5 Daewoo Pharm Latest Developments
13.10 Optaderm Pharma
13.10.1 Optaderm Pharma Company Information
13.10.2 Optaderm Pharma Ophthalmic Eye Dropper Product Portfolios and Specifications
13.10.3 Optaderm Pharma Ophthalmic Eye Dropper Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Optaderm Pharma Main Business Overview
13.10.5 Optaderm Pharma Latest Developments
13.11 Silgan Dispensing Systems
13.11.1 Silgan Dispensing Systems Company Information
13.11.2 Silgan Dispensing Systems Ophthalmic Eye Dropper Product Portfolios and Specifications
13.11.3 Silgan Dispensing Systems Ophthalmic Eye Dropper Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Silgan Dispensing Systems Main Business Overview
13.11.5 Silgan Dispensing Systems Latest Developments
14 Research Findings and Conclusion
*If Applicable.